Filing Details
Milestone Pharmaceuticals Inc. (NASDAQ:MIST) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 12, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:MIST
Milestone Pharmaceuticals Inc. (MIST) Files Quarterly Report for Q0
Milestone Pharmaceuticals Inc. (NASDAQ:MIST) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 12, 2026.
At publication ·
What changed
Milestone Pharmaceuticals Inc. (NASDAQ:MIST) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Milestone Pharmaceuticals Inc. (NASDAQ: MIST) filed its Q0 quarterly report (Form 10-Q) on August 12, 2026.
- The company's stock trades at $1.12 with a market capitalization of $252.5 million.
- The 10-Q filing includes unaudited financial statements and management commentary on business performance, though specific revenue figures were not disclosed in this summary.
Market Context
Milestone Pharmaceuticals Inc.'s stock currently trades at $1.12 with a market capitalization of $252.5M.
The 10-Q provides Milestone Pharmaceuticals Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Milestone Pharmaceuticals Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View MIST Stock Page
Frequently Asked Questions
Where can I read MIST's SEC filings?
Browse all filings on our MIST SEC filings page.
What types of SEC filings does Milestone Pharmaceuticals Inc. file?
Public companies like Milestone Pharmaceuticals Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.